Generic Name:
Cobimetinib
Project Status:
Complete
Therapeutic Area:
Metastatic melanoma
Manufacturer:
Hoffmann-la Roche Ltd.
Brand Name:
Cotellic
Project Line:
Reimbursement Review
Project Number:
PC0070-000
NOC Date:
Details
Strength:
20 mg tablet
Tumour Type:
Skin and Melanoma
Indications:
Metastatic Melanoma
Funding Request:
In combination vermurafenib, for the treatment of patients with unresectable or metastatic melanoma with BRAF V600 mutation
Review Status:
Complete
Pre Noc Submission:
Yes
Sponsor:
Hoffmann-la Roche Ltd.
Submission Date:
Submission Deemed Complete:
Prioritization Requested:
Not Requested
Stakeholder Input Deadline ‡:
Check-point meeting:
pERC Meeting:
Initial Recommendation Issued:
Feedback Deadline ‡:
Notification to Implement Issued:
Recommendation Type:
Reimburse with clinical criteria and/or conditions
pERC Meeting:
Final Recommendation Issued: